Sanofi's Genzyme Pulls 19 Lots Of Thymoglobulin Vials
Sanofi SA subsidiary Genzyme Corp. issued a voluntary recall of 19 lots of its kidney transplant rejection drug Thymoglobulin after discovering some lots of the drug may have stability issues, the...To view the full article, register now.
Already a subscriber? Click here to view full article